Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report

Descripción del Articulo

Pseudoepitheliomatous hyperplasia is a rare benign condition characterized by pronounced epidermal hyperplasia  that mimics carcinoma secondary to inflicted damage. Few cases have been described, all associated with tattooing. The most commonly used treatments consist of the application of topical c...

Descripción completa

Detalles Bibliográficos
Autor: Ortega Perez, Neith
Formato: artículo
Fecha de Publicación:2025
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/2902
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902
Nivel de acceso:acceso abierto
Materia:Fissure in Ano
Fibrosis
Hyperplasia
Botulinum Toxin
Fisura Anal
Hiperplasia
Toxina Botulínica
id REVHM_defe99f8683309ab7800d7e25cba20f1
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/2902
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
Hiperplasia pseudoepiteliomatosa por tratamiento de la fisura anal con toxina botulínica: reporte de caso
title Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
spellingShingle Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
Ortega Perez, Neith
Fissure in Ano
Fibrosis
Hyperplasia
Botulinum Toxin
Fisura Anal
Fibrosis
Hiperplasia
Toxina Botulínica
title_short Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
title_full Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
title_fullStr Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
title_full_unstemmed Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
title_sort Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case report
dc.creator.none.fl_str_mv Ortega Perez, Neith
author Ortega Perez, Neith
author_facet Ortega Perez, Neith
author_role author
dc.subject.none.fl_str_mv Fissure in Ano
Fibrosis
Hyperplasia
Botulinum Toxin
Fisura Anal
Fibrosis
Hiperplasia
Toxina Botulínica
topic Fissure in Ano
Fibrosis
Hyperplasia
Botulinum Toxin
Fisura Anal
Fibrosis
Hiperplasia
Toxina Botulínica
description Pseudoepitheliomatous hyperplasia is a rare benign condition characterized by pronounced epidermal hyperplasia  that mimics carcinoma secondary to inflicted damage. Few cases have been described, all associated with tattooing. The most commonly used treatments consist of the application of topical corticosteroids, surgical excision, CO2 laser curettage and topical 5-fluorouracil, the choice of which will depend on the extent of the affected area and the patient’s tolerance to treatment. We present the case of a 66-year-old female patient with a proctologic history (untreated chronic constipation) and an obstetric history (episiotomy), who sought medical attention for severe proctalgia related to a chronic anal fissure without an associated secondary cause and without improvement following topical medical treatment with calcium channel blockers and fiber. Considering the obstetric history, the initial treatment chosen was infiltration with botulinum toxin on both edges of the anal fissure, after which the condition worsened. Taking this into account, along with the physical examination of the anal fissure—with deeper ulceration and markedly fibrotic edges—a biopsy was performed, revealing pseudoepitheliomatous hyperplasia without atypia or carcinoma. The algorithm used to assess causality was that of the Spanish Pharmacovigilance System. The use of botulinum toxin for the treatment of anal fissure is increasingly widespread; however, there is no available literature on its long-term side effects. Therefore, patients should be followed up to identify unwanted side effects.
publishDate 2025
dc.date.none.fl_str_mv 2025-06-28
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902
10.24265/horizmed.2025.v25n2.13
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902
identifier_str_mv 10.24265/horizmed.2025.v25n2.13
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2189
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2262
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2310
dc.rights.none.fl_str_mv Derechos de autor 1970 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 1970 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/xml
text/html
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 25 No. 2 (2025): Abril-Junio; e2902
Horizonte Médico (Lima); Vol. 25 Núm. 2 (2025): Abril-Junio; e2902
Horizonte Médico (Lima); v. 25 n. 2 (2025): Abril-Junio; e2902
2227-3530
1727-558X
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1851062175430344704
spelling Pseudoepitheliomatous hyperplasia due to botulinum toxin treatment for anal fissure: a case reportHiperplasia pseudoepiteliomatosa por tratamiento de la fisura anal con toxina botulínica: reporte de caso Ortega Perez, Neith Fissure in Ano Fibrosis Hyperplasia Botulinum Toxin Fisura Anal Fibrosis Hiperplasia Toxina BotulínicaPseudoepitheliomatous hyperplasia is a rare benign condition characterized by pronounced epidermal hyperplasia  that mimics carcinoma secondary to inflicted damage. Few cases have been described, all associated with tattooing. The most commonly used treatments consist of the application of topical corticosteroids, surgical excision, CO2 laser curettage and topical 5-fluorouracil, the choice of which will depend on the extent of the affected area and the patient’s tolerance to treatment. We present the case of a 66-year-old female patient with a proctologic history (untreated chronic constipation) and an obstetric history (episiotomy), who sought medical attention for severe proctalgia related to a chronic anal fissure without an associated secondary cause and without improvement following topical medical treatment with calcium channel blockers and fiber. Considering the obstetric history, the initial treatment chosen was infiltration with botulinum toxin on both edges of the anal fissure, after which the condition worsened. Taking this into account, along with the physical examination of the anal fissure—with deeper ulceration and markedly fibrotic edges—a biopsy was performed, revealing pseudoepitheliomatous hyperplasia without atypia or carcinoma. The algorithm used to assess causality was that of the Spanish Pharmacovigilance System. The use of botulinum toxin for the treatment of anal fissure is increasingly widespread; however, there is no available literature on its long-term side effects. Therefore, patients should be followed up to identify unwanted side effects.La hiperplasia pseudoepiteliomatosa es una rara patología benigna caracterizada por una hiperplasia epidérmica intensa que simula un carcinoma secundario a un daño infligido. Se han descrito pocos casos y todos asociados a la realización de tatuajes. Los tratamientos más utilizados consisten en la aplicación de corticoides tópicos, escisión quirúrgica, curetaje con láser CO2 y 5-fluorouracilo tópico, cuya elección va a depender de la extensión del área afectada y de la tolerancia al tratamiento. Se presenta el caso de una paciente de 66 años con antecedentes proctológicos (estreñimiento crónico sin tratamiento) y obstétricos (episiotomía), que acudió a consulta por proctalgia intensa relacionada con una fisura anal crónica sin causa secundaria asociada y sin mejoría con el tratamiento médico tópico con calcioantagonistas y fibra. Dado el antecedente obstétrico, se decidió tratar inicialmente con infiltración de toxina botulínica sobre ambos bordes de la fisura, tras la cual empeoró. Tomando ello en consideración, así como la exploración física de la fisura anal —con ulceración más profunda y bordes con intensa fibrosis—, se realizó una biopsia con resultado de hiperplasia pseudoepiteliomatosa sin atipias ni carcinomas. El algoritmo que se utilizó para valorar la causalidad fue el del Sistema Español de Farmacovigilancia. El uso de la toxina botulínica para el tratamiento de la fisura anal cada vez está más extendido; no obstante, no existe bibliografía disponible con los efectos secundarios a largo plazo, por lo que se debe realizar un seguimiento de los pacientes para detectar efectos secundarios no deseados.Universidad de San Martín de Porres. Facultad de Medicina Humana2025-06-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmltext/htmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/290210.24265/horizmed.2025.v25n2.13Horizonte Médico (Lima); Vol. 25 No. 2 (2025): Abril-Junio; e2902Horizonte Médico (Lima); Vol. 25 Núm. 2 (2025): Abril-Junio; e2902Horizonte Médico (Lima); v. 25 n. 2 (2025): Abril-Junio; e29022227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspahttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2189https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2262https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2902/2310Derechos de autor 1970 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/29022025-06-28T19:53:36Z
score 13.037274
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).